Bullpen.News · the best place to find stock ideas

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $43B

WHAT ARE WE DOING? “Contrarians At The Gate” 21h ago 43 clicks

24h ago APP $88B

AppLovin Deep Dive

Speedwell Research 19 clicks

31h ago STZ $22B

Constellation: Stars Aligning?

TSOH Investment Research 24 clicks

From X

@ACapitalLP Sep 23 1 click

A Capital on X

Perception <> Reality $OWL selling off on a $1bn Loparex restructuring headline, despite having already marked its second-lien exposure to 5 cents on the dollar at June 30, down from 63 cents in March. That excludes any potential equity recovery… Thx for the “gift” Bloomberg… https://t.co/5p1wrv5PzL

@aleabitoreddit Sep 23

Serenity on X

So update from $LITE + Win Semi ( $SIVE ) foundry: Lumentum in a meeting with Stifel at ECOC 2026 stated: - $NVDA Spectrum-6 CPO UHP demands increased materially. - NPO as larger than CPO, with multi-wavelength external lasers lifting ASPs (Sivers offers multi wave length DFB arrays, read through on higher valued products) - Demand for UHP lasers continues to exceed supply Just a status update in terms of how the optical bottleneck is going (laser prices going up, demand exceeds supply). Digitimes also reported today Win Semi ( $SIVE foundry ) was expanding capacity for CW lasers. - "CW products... are expected to gradually emerge in the second half of 2026", with meaningful revenue contribution likely coming in 2027 and 2028. - Win has strengthened inventory management for InP substrates while moving toward 6-in InP wafers for ongoing process testing. Currently relies on Tier-1 International suppliers. - Many of this was spent on DUV tools from $ASML but (Win Semi's orders spanned machinery, equipment, and fab engineering work) So that answers a lot of questions about Sivers' partner "how is this company securing InP substrates", "4in vs 6in", "production timing" TLDR: - NPO > CPO (per Lite), multi-wavelength lasers going brrr for prices - demand > supply (continuation) - Not sure why people have been bear posting Win Semi when turns out they have everything needed to mass produce CW lasers.

@leevalueroach Sep 23

Lee Roach on X

This is why I’m long $GME. Because of dumb Disney Adults. Go there sometime. It’s a bunch of adults without kids acting like children. Now these Disney adults are piling into trading cards. They are reliving their childhood because they will never have kids of their own. Even Toys R Us is reopening to target these morons. It’s turbo time.

@junkbondinvest Sep 23

junkbondinvestor on X

Remember during COVID, $RCL was raising debt (secured by 28 of its own ships btw) at 11% just to stay alive? Well, they just agreed to pay $3bn for Sandals, the biggest deal in its history 6 years ago, the question was whether they would still exist...how times change https://t.co/qsdrXBcHhA

@kab604 Sep 23

kab60 on X

It's always weird when analysts don't address the elephant in the room - you'd think things were going splendid at $CHTR and they were running with net cash: https://t.co/NPBWGrKxuQ

@ACapitalLP Sep 23 1 click

A Capital on X

$LPLA’s customer is the independent financial advisor, not the end investor. Advisors own the client relationship. LPL provides the custody, compliance and infrastructure. The idea that Muse justifies a 7.5% selloff is perception <> reality… https://t.co/VA013VwL2T

@MaiusPartners Sep 22 4 clicks

Maius on X

Love it or hate it, but the $GNRC / $AMZN deal is an extremely bearish read-through for the legacy backup power suppliers $CMI / $CAT. The equivalent would be $GM coming to China and taking 20% of the market overnight from BYD. https://t.co/loOU0ZaB7V

@BarbarianCap Sep 22 4 clicks

Barbarian Capital on X

AutoZone Expects Growth to Accelerate This Fiscal Year $AZO https://t.co/FYkgVNrID5

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…

CMG $39B

Yet Another Value Podcast Oct 14 84 clicks

Everyone wants to defend CoreWeave but who really knows

CoreWeave faces fresh skepticism as another AI trade selloff collides with bullish defenses of the company.

CRWV $43B

The Technology Letter 41h ago 2 clicks

A Conversation With Ari Emanuel About Entertainment and AI

Ari Emanuel discusses AI’s impact on Hollywood, live events, social networks and the future of advertising.

TKO $33B

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. 41h ago 6 clicks

Coherent | Management Call

COHR $52B

P Equity Research Oct 14 17 clicks

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TEVA $48B

Equity Eagle Oct 14 7 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $86BJBHT $22B

Monte Independent Investment Research Oct 14 12 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $17B

Latticework by MOI Global Oct 14 13 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B

Latticework by MOI Global Oct 14 13 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B

Latticework by MOI Global Oct 14 11 clicks

Insider activity September 2026

Asian insider buying rose 19% to US$2.4 billion across 930 September transactions, led by Grab CEO Anthony Tan’s US$30 million purchase…

GRAB $12B

Asian Century Stocks Oct 14 6 clicks

Rollins (ROL), Verisure (VSURE), and the cost of standing still (Part 2, Verisure)

Verisure’s 6.38 million monitored-alarm subscribers generate 90% recurring revenue, while its disclosed acquisition costs and 6%-8% churn…

ROL $15B

Best Anchor Stocks Oct 13 23 clicks

BridgeBio: Maintaining 'Strong Buy' Additional Encaleret Data ADH1 And Three Expected FDA Reviews

BridgeBio Pharma reported Q2 revenue of $243.7 million and has three Priority Review NDAs, while $1 billion in convertible preferred…

BBIO $13B

Terry Chrisomalis Oct 13 2 clicks

AMADF · long

Amadeus It Group SA

Amadeus IT Group turns long after shares fell more than 20% since a November short call.

AMADF $25B

Value Investors Club Jul 15 1 click

Expectations going higher for Everpure, DigitalOcean

Everpure and DigitalOcean face rising expectations as their stock prices shape Monday’s views.

DOCN $13B

The Technology Letter Oct 12 6 clicks

Vicor Update, Part Two

Vicor uses ITC exclusion-order cases to license power-module patents, with published royalty multipliers rising from 1.0x before filing to…

VICR $10B

CV's Substack Oct 12 4 clicks

Rubrik (NYSE: RBRK) Stock Rating: DISTRIBUTE After Q2 FY1/27 Earnings

Rubrik posted 38% Q2 revenue growth to $427.3 million, but Cloud ARR growth slowed to 39% and its enterprise value reached 15.7 times…

RBRK $25B

Cestrian Capital Research Oct 12 3 clicks

Expert Call | Nebius

Nebius’s 1 GW annual active-capacity target from 2027 is realistic, according to a former product manager, with greenfield data centers…

NBIS $56B

P Equity Research Oct 12 4 clicks

Q3 2026 Jenga IP Quarterly Letter

Jenga Global Master Fund returned 8.10% in Q3 2026, added Adobe and Mexican airports, and later initiated S&P Global.

ADBE $98B

Global Outperformers Oct 12 3 clicks

Howmet Aerospace: Strong Q2, But The Valuation Is Too Rich

Howmet Aerospace posted 24% Q2 revenue growth and 46% adjusted EPS growth, but HWM trades about 87% above a $120.69 DCF fair-value estimate.

HWM $86B

Alexander I. Velasquez Oct 12 2 clicks

LQDA: finer powder, higher doses

Liquidia’s Yutrepia sales reached $170.4 million in Q2 2026, while a patent ruling threatens its PH-ILD label but leaves PAH sales and a…

UTHR $24B

Trade Ideas Flow Oct 12 4 clicks

Latest News

A Capital on X

Serenity on X

Lee Roach on X

junkbondinvestor on X

kab60 on X

A Capital on X

Maius on X

Barbarian Capital on X

Investor Letters

Recent recaps

Latest recap

Publications we follow

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 49 of 231

X accounts we follow

Investor letters we follow

Sectors